Description

Ethyl 3-(5-Methyl-7-Oxo-4,7-Dihydropyrazolo-[1,5-A]Pyrimidin-6-Yl)Propanoate is a high-purity, advanced pharmaceutical intermediate designed for the synthesis of complex active pharmaceutical ingredients (APIs). This compound is critical for research and development in medicinal chemistry, offering a versatile building block for creating novel therapeutic agents. It is primarily utilized by pharmaceutical manufacturers, biotechnology R&D labs, and fine chemical synthesis specialists seeking reliable and high-quality raw materials for their production pipelines.

Application

• Pharmaceutical Intermediate: A key building block in the synthesis of novel drug candidates, particularly in the development of kinase inhibitors and other targeted therapies.
• Medicinal Chemistry Research: Used in lead optimization and structure-activity relationship (SAR) studies to develop new chemical entities with potential biological activity.
• Fine Chemical Synthesis: Serves as a versatile precursor for the production of more complex heterocyclic compounds in custom synthesis projects.
• Contract Research & Manufacturing (CRAM): Supplied to organizations specializing in the development and scale-up of pharmaceutical processes from laboratory to commercial scale.
• Academic Research: Utilized in university and institutional labs for studying synthetic methodologies and the properties of fused pyrazolopyrimidine systems.

Basic Information

Product Name	Ethyl 3-(5-Methyl-7-Oxo-4,7-Dihydropyrazolo-[1,5-A]Pyrimidin-6-Yl)Propanoate
CAS No.	1158194-94-5
Molecular Formula	C12H15N3O3
Molecular Weight	249.27 g/mol
Synonyms	Ethyl 3-(5-methyl-7-oxo-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)propanoate; 6-(2-Ethoxycarbonylethyl)-5-methyl-4,7-dihydro-7-oxopyrazolo[1,5-a]pyrimidine; Propanoic acid, 3-(5-methyl-7-oxo-4,7-dihydro-1H-pyrazolo[1,5-a]pyrimidin-6-yl)-, ethyl ester; Ethyl 3-(5-methyl-7-oxo-4H,7H-pyrazolo[1,5-a]pyrimidin-6-yl)propionate; CAS 1158194-94-5
EINECS	Contact for details

Quality Control

Our Ethyl 3-(5-Methyl-7-Oxo-4,7-Dihydropyrazolo-[1,5-A]Pyrimidin-6-Yl)Propanoate is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) with detailed specifications are provided for each batch to guarantee traceability, consistency, and compliance with your project requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider storing under an inert atmosphere to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.